Kuras Magdalena
Department of Biomedical Engineering, Lund University, 221 00 Lund, Sweden.
Section for Clinical Chemistry, Department of Translational Medicine, Lund University, 205 02 Malmö, Sweden.
Int J Mol Sci. 2023 Sep 21;24(18):14403. doi: 10.3390/ijms241814403.
Malignant melanoma is a very aggressive skin cancer, characterized by a heterogeneous nature and high metastatic potential. The incidence of melanoma is continuously increasing worldwide, and it is one of the most common cancers in young adults. In the past twenty years, our understanding of melanoma biology has increased profoundly, and disease management for patients with disseminated disease has improved due to the emergence of immunotherapy and targeted therapy. However, a significant fraction of patients relapse or do not respond adequately to treatment. This can partly be explained by the complex signaling between the tumor and its microenvironment, giving rise to melanoma phenotypes with different patterns of disease progression. This review focuses on the key aspects and complex relationship between pathogenesis, genetic abnormalities, tumor microenvironment, cellular plasticity, and metabolic reprogramming in melanoma. By acquiring a deeper understanding of the multifaceted features of melanomagenesis, we can reach a point of more individualized and patient-centered disease management and reduced costs of ineffective treatments.
恶性黑色素瘤是一种极具侵袭性的皮肤癌,其特点是具有异质性和高转移潜能。黑色素瘤的发病率在全球范围内持续上升,是年轻成年人中最常见的癌症之一。在过去二十年中,我们对黑色素瘤生物学的理解有了深刻的提高,由于免疫疗法和靶向疗法的出现,播散性疾病患者的疾病管理也有所改善。然而,相当一部分患者会复发或对治疗反应不佳。这在一定程度上可以通过肿瘤与其微环境之间复杂的信号传导来解释,从而产生具有不同疾病进展模式的黑色素瘤表型。本综述重点关注黑色素瘤发病机制、基因异常、肿瘤微环境、细胞可塑性和代谢重编程之间的关键方面和复杂关系。通过更深入地了解黑色素瘤发生的多方面特征,我们能够实现更个体化、以患者为中心的疾病管理,并降低无效治疗的成本。